Pfizer Drug Supply Deal Draws Antitrust Scrutiny

Law360, New York (February 16, 2007, 12:00 AM EST) -- Regulators in the United Kingdom are reportedly nearing a decision on whether a controversial deal between Pfizer Inc. and UniChem that would force pharmacists to purchase medicines directly from the American pharmaceutical giant would harm competition in the drug industry.

The United Kingdom’s Office of Fair Trading, which has been evaluating the impact of the proposed changes on competition in the pharmaceutical sector since the end of last year, may announce its decision on the deal in a report on the U.K. Pharmaceutical Pricing Regulation Scheme...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.